Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
- PMID: 10604722
- PMCID: PMC2362975
- DOI: 10.1038/sj.bjc.6694262
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
Abstract
It is proposed that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal tumorigenesis by inhibition of cyclooxygenase (COX). COX is a key enzyme in the conversion of arachidonic acid to prostaglandins and two isoforms of COX have been characterized, COX-1 and COX-2. Multiple studies have shown that COX-2 is expressed at high levels in colorectal tumours and play a role in colorectal tumorigenesis. Recently it has been reported that selective inhibition of COX-2 inhibits colon cancer cell growth. In this study we investigated the effect of a selective COX-2 inhibitor (JTE-522) on haematogenous metastasis of colon cancer. For this purpose, we selected a murine colon cancer cell line, colon-26, that constitutively expresses the COX-2 protein. The subclone P expressed a high level of COX-2 and the subclone 5 expressed a low level. The colon-26 subclones were injected into the tail vein of BALB/c mice. JTE-522 was given intraperitoneally every day from the day prior to cancer cell injection, and the mice were sacrificed 16 days after cell injection. Lung metastases were compared between groups with and without JTE-522. In the mice injected with subclone P, the number of lung metastatic nodules was significantly reduced in the treated group. However, in the mice injected with subclone 5, there was little difference between the control and the treated groups. These results indicate that there may be a direct link between inhibition of haematogenous metastasis of colon cancer and selective inhibition of COX-2, and that selective COX-2 inhibitors may be a novel class of therapeutic agents not only for colorectal tumorigenesis but also for haematogenous metastasis of colon cancer.
Similar articles
-
The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.Anticancer Res. 2003 Jan-Feb;23(1A):245-9. Anticancer Res. 2003. PMID: 12680220
-
JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.BMC Cancer. 2005 Mar 3;5:26. doi: 10.1186/1471-2407-5-26. BMC Cancer. 2005. PMID: 15743541 Free PMC article.
-
Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.Int J Cancer. 2002 Aug 10;100(5):515-9. doi: 10.1002/ijc.10508. Int J Cancer. 2002. PMID: 12124799
-
[COX-2 inhibitor and colon cancer].Gan To Kagaku Ryoho. 2001 Nov;28(12):1799-805. Gan To Kagaku Ryoho. 2001. PMID: 11729471 Review. Japanese.
-
Approach to angiogenesis inhibition based on cyclooxygenase-2.Cancer J. 2001 Nov-Dec;7 Suppl 3:S144-50. Cancer J. 2001. PMID: 11779086 Review.
Cited by
-
Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.Cancer Sci. 2005 Feb;96(2):93-9. doi: 10.1111/j.1349-7006.2005.00022.x. Cancer Sci. 2005. PMID: 15723653 Free PMC article.
-
Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.Jpn J Cancer Res. 2002 Oct;93(10):1175-81. doi: 10.1111/j.1349-7006.2002.tb01220.x. Jpn J Cancer Res. 2002. PMID: 12417048 Free PMC article.
-
Use of aspirin postdiagnosis improves survival for colon cancer patients.Br J Cancer. 2012 Apr 24;106(9):1564-70. doi: 10.1038/bjc.2012.101. Epub 2012 Mar 27. Br J Cancer. 2012. PMID: 22454078 Free PMC article.
-
Cyclooxygenase-2 and its role in colorectal cancer development.Virchows Arch. 2004 Oct;445(4):327-33. doi: 10.1007/s00428-004-1105-2. Epub 2004 Sep 1. Virchows Arch. 2004. PMID: 15340847 Review.
-
Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus.BMC Cancer. 2006 May 19;6:134. doi: 10.1186/1471-2407-6-134. BMC Cancer. 2006. PMID: 16712734 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials